443 related articles for article (PubMed ID: 36937566)
21. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression.
Rezai-Zadeh K; Ehrhart J; Bai Y; Sanberg PR; Bickford P; Tan J; Shytle RD
J Neuroinflammation; 2008 Sep; 5():41. PubMed ID: 18817573
[TBL] [Abstract][Full Text] [Related]
22. Herbal medicinal products or preparations for neuropathic pain.
Boyd A; Bleakley C; Hurley DA; Gill C; Hannon-Fletcher M; Bell P; McDonough S
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD010528. PubMed ID: 30938843
[TBL] [Abstract][Full Text] [Related]
23. Oxycodone for neuropathic pain and fibromyalgia in adults.
Gaskell H; Moore RA; Derry S; Stannard C
Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
[TBL] [Abstract][Full Text] [Related]
24. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
[TBL] [Abstract][Full Text] [Related]
25. An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders.
Taliou A; Zintzaras E; Lykouras L; Francis K
Clin Ther; 2013 May; 35(5):592-602. PubMed ID: 23688534
[TBL] [Abstract][Full Text] [Related]
26. Effects of intrathecal and intracerebroventricular administration of luteolin in a rat neuropathic pain model.
Hara K; Haranishi Y; Terada T; Takahashi Y; Nakamura M; Sata T
Pharmacol Biochem Behav; 2014 Oct; 125():78-84. PubMed ID: 25196931
[TBL] [Abstract][Full Text] [Related]
27. Effect of Luteolin and Apigenin on the Production of Il-31 and Il-33 in Lipopolysaccharides-Activated Microglia Cells and Their Mechanism of Action.
Che DN; Cho BO; Kim JS; Shin JY; Kang HJ; Jang SI
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204450
[TBL] [Abstract][Full Text] [Related]
28. Immunopharmacological Activities of Luteolin in Chronic Diseases.
Huang L; Kim MY; Cho JY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768462
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma.
Kempuraj D; Thangavel R; Kempuraj DD; Ahmed ME; Selvakumar GP; Raikwar SP; Zaheer SA; Iyer SS; Govindarajan R; Chandrasekaran PN; Zaheer A
Biofactors; 2021 Mar; 47(2):190-197. PubMed ID: 33098588
[TBL] [Abstract][Full Text] [Related]
30. Exploring the Antiglioma Mechanisms of Luteolin Based on Network Pharmacology and Experimental Verification.
Huang R; Dong R; Wang N; Lan B; Zhao H; Gao Y
Evid Based Complement Alternat Med; 2021; 2021():7765658. PubMed ID: 34873410
[TBL] [Abstract][Full Text] [Related]
31. Topical clonidine for neuropathic pain.
Wrzosek A; Woron J; Dobrogowski J; Jakowicka-Wordliczek J; Wordliczek J
Cochrane Database Syst Rev; 2015 Aug; 8(8):CD010967. PubMed ID: 26329307
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of metastasis suppression by luteolin in breast cancer.
Cook MT
Breast Cancer (Dove Med Press); 2018; 10():89-100. PubMed ID: 29928143
[TBL] [Abstract][Full Text] [Related]
33. Antidepressants for chronic non-cancer pain in children and adolescents.
Cooper TE; Heathcote LC; Clinch J; Gold JI; Howard R; Lord SM; Schechter N; Wood C; Wiffen PJ
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012535. PubMed ID: 28779487
[TBL] [Abstract][Full Text] [Related]
34. Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on
Taheri Y; Sharifi-Rad J; Antika G; Yılmaz YB; Tumer TB; Abuhamdah S; Chandra S; Saklani S; Kılıç CS; Sestito S; Daştan SD; Kumar M; Alshehri MM; Rapposelli S; Cruz-Martins N; Cho WC
Oxid Med Cell Longev; 2021; 2021():1987588. PubMed ID: 34594472
[TBL] [Abstract][Full Text] [Related]
35. Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activity.
Yang SC; Chen PJ; Chang SH; Weng YT; Chang FR; Chang KY; Chen CY; Kao TI; Hwang TL
Biochem Pharmacol; 2018 Aug; 154():384-396. PubMed ID: 29883707
[TBL] [Abstract][Full Text] [Related]
36. A superoxide-mediated mitogen-activated protein kinase phosphatase-1 degradation and c-Jun NH(2)-terminal kinase activation pathway for luteolin-induced lung cancer cytotoxicity.
Bai L; Xu X; Wang Q; Xu S; Ju W; Wang X; Chen W; He W; Tang H; Lin Y
Mol Pharmacol; 2012 Apr; 81(4):549-55. PubMed ID: 22222766
[TBL] [Abstract][Full Text] [Related]
37. Effects of luteolin on treatment of psoriasis by repressing HSP90.
Lv J; Zhou D; Wang Y; Sun W; Zhang C; Xu J; Yang H; Zhou T; Li P
Int Immunopharmacol; 2020 Feb; 79():106070. PubMed ID: 31918062
[TBL] [Abstract][Full Text] [Related]
38. Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review.
Muruganathan N; Dhanapal AR; Baskar V; Muthuramalingam P; Selvaraj D; Aara H; Shiek Abdullah MZ; Sivanesan I
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422285
[TBL] [Abstract][Full Text] [Related]
39. Desipramine for neuropathic pain in adults.
Hearn L; Moore RA; Derry S; Wiffen PJ; Phillips T
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD011003. PubMed ID: 25246131
[TBL] [Abstract][Full Text] [Related]
40. Oral nonsteroidal anti-inflammatory drugs for neuropathic pain.
Moore RA; Chi CC; Wiffen PJ; Derry S; Rice AS
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010902. PubMed ID: 26436601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
